Home / Inspections / 1231009

FDA Inspection 1231009 — Pfizer Ireland Pharmaceuticals Unlimited Company

Pfizer Ireland Pharmaceuticals Unlimited Company — FEI 3006785053

The FDA completed an inspection of Pfizer Ireland Pharmaceuticals Unlimited Company on September 23, 2022 in Newbridge. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 23, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newbridge (Ireland)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1128858 (VAI Fri Sep 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1053147 (NAI Fri Apr 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 980507 (VAI Fri Jul 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 933818 (VAI Fri Jun 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 821768 (NAI Fri Feb 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources